Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.

Publication Year: 2013

DOI:
10.1111/crj.12026

PMCID:
PMC4352333

PMID:
23578031

Journal Information

Full Title: Clin Respir J

Abbreviation: Clin Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest J.C. has received investigator and travel fees for his role in conducting multicentre clinical trials organised by GlaxoSmithKline, administered by his employer facility IPS Research, which has also received site funding and support in association with such trials, which include the study described in this work. I.S. declares no conflicts of interest.A.A., R.T., W.H., N.G. and L.J. are employees of and hold stock/shares in GlaxoSmithKline. All authors meet the criteria for authorship set forth by the International Committee for Medical Journal Editors, had full access to and interpreted the data, and wrote the manuscript. All authors vouch for the accuracy and completeness of the data and the data analysis. "

Evidence found in paper:

"Funding This study was funded by GlaxoSmithKline (GSK study number HZA106851; http://www.clinicaltrials.gov registration number NCT01086410). "

Evidence found in paper:

"This phase 3 study (GSK study number HZA106851; http://www.clinicaltrials.gov registration number NCT01086410) was conducted at 16 centres in three countries (Germany, Poland, United States) between 25 March 2010 and 24 September 2010. The study was approved by local ethics review committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Written informed consent was obtained from each patient prior to the performance of any study-specific procedures. Funding This study was funded by GlaxoSmithKline (GSK study number HZA106851; http://www.clinicaltrials.gov registration number NCT01086410). "

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025